Clinical Trial Update: A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by Janssen evaluated the clinical utility of measuring antipsychotic medication levels in plasma using LC-MS/MS. The study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Antipsychotic plasma level assay (unspecified)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29